79256886 - IFOM

Information

• Trademark
• 79256886

• Source

• Serial Number

  79256886

• Registration Number

  6297449

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  September 20, 2018
  6 years ago

• Registration Date

  March 23, 2021
  3 years ago

• Transaction Date

  May 28, 2023
  a year ago

• Status Date

  March 23, 2021
  3 years ago

• Published for Opposition Date

  June 02, 2020
  4 years ago

• Location Date

  March 23, 2021
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  EBAUGH, MICHAEL THOMAS

• Attorney Docket Number

  2048-TM-175

  Attorney Name

  KENNETH F FLOREK

  Law Office Assigned Location Code

  L80

• Owners

  • IFOM Fondazione Istituto FIRC di Oncologia Molecolare

Case File Statements

• DM0000: The mark consists of the wording "IFOM" in special characters and underlined by a line. Moreover, a stylized representation of a microscope starts from the line and partially overlaps with the letter "O".
• GS0051: Pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the prevention of disorders of the skeletal system; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of disorders of the central nervous system related to cancer, aging and metabolic diseases; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of disorders of the circulatory system related to aging; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of hormonal disorders and diabetes; pharmaceutical cough preparations; preparations for treating colds; pharmaceutical preparations for the treatment of flu and headache; pharmaceutical preparations for the treatment of stomach disorders; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for treating muscular and/or rheumatological diseases; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergies; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for use in oncology; diagnostic preparations and reagents for medical use in a clinic or medical laboratory; hormones; dietetic substances adapted for medical use, in particular, nutritional supplements, vitamin preparations, herbal supplements and preparations, nutritional drink mixes for use as meal replacements for medical use, meal replacement snacks for medical purposes; food and drinks for babies, infant formula and dietetic products for invalids, in particular food for babies, powdered milk for babies, foods for enteral feedings and dietetic foods adapted for medical purposes
• CC0000: Color is not claimed as a feature of the mark.
• GS0441: Medical services, health care services in the field of oncology, aging and metabolic diseases, medical assistance, physical rehabilitation in the field of oncology; hospital services; consulting services in the field of medical care, namely, consultancy in the field of medical diagnosis, medical analysis and RNA or DNA analysis for cancer diagnosis and prognosis; consulting services relating to health care
• GS0421: Scientific and technological services, namely, scientific research, analysis, testing, diagnosis and screening in the field of oncology and cancer research; research and development in the field of oncology, aging and metabolic diseases; scientific and industrial research and analysis services, namely, scientific research, analysis, testing in the field of medicine; biological research and analysis; scientific, clinical and medical research in the field of radiology, chemotherapy, pharmacotherapy, coronary artery bypass surgery; basic and clinical research in the field of genetics, stem cell, immunodeficiency and neurodegenerative diseases, proteomics, bioinformatics, neurobiology and molecular biology and diabetes; scientific research in the field of medicine; consultancy in the field of scientific analysis; none of the foregoing to include educational testing

Case File Event Statements

• 5/28/2023 - a year ago

  49 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 8/14/2021 - 3 years ago

  48 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 7/1/2021 - 3 years ago

  47 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS

• 7/1/2021 - 3 years ago

  46 - GENERIC MADRID TRANSACTION CREATED Type: XXCR

• 6/23/2021 - 3 years ago

  45 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 3/23/2021 - 3 years ago

  44 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/16/2021 - 3 years ago

  43 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN

• 2/16/2021 - 3 years ago

  42 - OPPOSITION TERMINATED NO. 999999 Type: OP.T

• 2/16/2021 - 3 years ago

  41 - OPPOSITION DISMISSED NO. 999999 Type: OP.D

• 12/26/2020 - 3 years ago

  40 - REFUSAL PROCESSED BY IB Type: RFNP

• 12/7/2020 - 3 years ago

  39 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I

• 12/1/2020 - 3 years ago

  38 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS

• 12/1/2020 - 3 years ago

  37 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC

• 10/10/2020 - 4 years ago

  36 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 9/23/2020 - 4 years ago

  35 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 9/23/2020 - 4 years ago

  34 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 6/30/2020 - 4 years ago

  33 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 6/2/2020 - 4 years ago

  32 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/2/2020 - 4 years ago

  31 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/29/2020 - 4 years ago

  30 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/13/2020 - 4 years ago

  29 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 5/13/2020 - 4 years ago

  28 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 5/13/2020 - 4 years ago

  27 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/24/2020 - 4 years ago

  26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/17/2020 - 4 years ago

  25 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/17/2020 - 4 years ago

  24 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/17/2020 - 4 years ago

  23 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/17/2020 - 4 years ago

  22 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/17/2020 - 4 years ago

  21 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 12/18/2019 - 4 years ago

  20 - WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST Type: PBSR

• 12/11/2019 - 4 years ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/10/2019 - 4 years ago

  18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/10/2019 - 4 years ago

  17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/10/2019 - 4 years ago

  16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/10/2019 - 4 years ago

  15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 11/18/2019 - 4 years ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/18/2019 - 4 years ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/18/2019 - 4 years ago

  12 - ASSIGNED TO LIE Type: ALIE

• 11/12/2019 - 4 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/22/2019 - 5 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 5/31/2019 - 5 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/31/2019 - 5 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 5/8/2019 - 5 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 5/7/2019 - 5 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/4/2019 - 5 years ago

  5 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/30/2019 - 5 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/30/2019 - 5 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/29/2019 - 5 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 4/18/2019 - 5 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR